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Cadmium in the Mammary Gland and Neonatal Intestine - 
Transport Pathways and Interactions with Calcium and Iron 
Abstract 
Cadmium is a ubiquitous toxic metal known to cause several adverse health effects 
in humans. Newborns have an increased gastrointestinal absorption of cadmium 
compared to adults and seem to be more sensitive to cadmium toxicity. The well-
established association in adults between increased uptake of dietary cadmium and 
low iron status has not been investigated in newborns. The aim of this thesis was to 
study cadmium during the neonatal period, focusing on intracellular transport 
pathways and interactions of cadmium with calcium and iron.  
Cadmium-induced effects on the lactating mammary gland were investigated in 
mice and in murine mammary epithelial HC11 cells. Cadmium reduced total 
intracellular calcium levels, expression of secretory pathway calcium-ATPase 
(SPCA) and β-casein gene expression both in vivo and in vitro. An involution-like 
remodeling of the mammary tissue, including increased fat content, was observed 
following cadmium exposure. The results indicate that cadmium disturbs the 
function of the mammary gland by reducing calcium, SPCA and β-casein levels in 
secreting mammary cells.  
The impact of iron status on cadmium transport across the neonatal intestine was 
investigated in suckling piglets and in human immature intestinal epithelial Caco-2 
cells. High iron status did not restrict cadmium absorption in the piglets; instead 
increased cadmium absorption was detected. Similar results were obtained in 
immature Caco-2 cells. Gene and protein expressions and localizations of the iron 
transporters DMT1, DMT1-IRE and FPN1 were not affected by iron status, 
indicating that the mechanism regulating iron absorption is age-dependent. Gene 
expression of multidrug resistance associated protein 1 (MRP1) was increased in the 
immature intestinal cells treated with cadmium and correlated to increased transport 
of cadmium across the cells.  
In conclusion, cadmium exposure may decrease both calcium and protein levels 
in milk with potential negative developmental effects in the neonate. Furthermore, 
iron supplementation does not restrict, but rather increases cadmium absorption in 
newborns, which should be considered in risk assessment of cadmium.  
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To you with interest in the whole mighty cadmium puzzle consisting of 
more than 29 000 scientific papers. 
Science is not about control. It is about cultivating a perpetual condition of wonder in 
the face of something that forever grows one step richer and subtler than our latest 
theory about it. It is about reverence, not mastery. 
Richard Powers (1991)  
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1  Introduction 
Cadmium has since 1858 been known to cause toxic effects in humans 
(Nordberg, 2009; Sovet, 1858). Today the metal is widely spread in our 
environment, naturally occurring as well as due to human activities. No 
biological function of cadmium has been identified but several adverse 
health effects in humans are caused by the metal. Cadmium is a divalent 
metal and have the ability to mimic other divalent metals e.g. calcium and 
iron. The interference with the homeostasis of these essential metals is 
fundamental for the cellular toxicity of cadmium. Virtually all food contains 
cadmium in varying concentrations; consequently, diet is the main source of 
cadmium for the general population. A large part of the adult population in 
Europe has a current intake of cadmium that is close to the tolerable dietary 
intake (EFSA, 2009).  
 
Newborns and infants have a different exposure pattern and an increased 
absorption of cadmium than adults (Eklund et al., 2001; Crews et al., 2000). 
In general, newborns are considered to be more susceptible than adults to 
adverse health effects caused by environmental pollutants (Landrigan, 2004). 
The neonatal period (newborn period) continues until the newborn is four 
weeks old and this period is characterized by rapid growth and development 
of the neonate. During the neonatal period the central nervous system is 
particularly vulnerable due to the great evolvement and cadmium has been 
demonstrated to affect it, resulting in neurochemical and neurobehavioral 
effects (Petersson Grawé et al., 2004b; Andersson et al., 1997). Recently, 
The European Food Safety Authority (EFSA) stated that the tolerable 
dietary intake of cadmium in European children might be exceeded about 
two-fold (EFSA, 2009).  
   12
In 1758 Carl von Linné named the group of animals able to produce milk 
for their offspring Mammalia. The great advantage in having the capacity to 
nourish the offspring in any environment has been crucial for the strong 
evolution of mammals. In all mammals there is a close relationship between 
lactating mammary and neonatal gastrointestinal functions. The mammary 
gland produces milk containing essential nutrients, as well as protective, 
trophic and digestive factors, all tightly regulated and efficiently transferred 
from the mother to the neonate (Figure 1). The neonatal intestine is 
dependent on milk to compensate for the immature digestive and barrier 
functions (Le Huerou-Luron et al., 2010). There is an intimate connection 
and a close interplay between the mammary gland and neonatal intestine, 
which in turn is necessary for adaptation to extrauterine life as well as health 
and development of the neonate.  
 
Figure 1. Interplay between mammary gland and neonatal intestine along with the transfer of 
important nutrients and immunoglobulins from the mother to the newborn.    13
2  Background 
2.1  Cadmium exposure and adverse health effects 
Cadmium is a toxic metal naturally occurring in soil, but is also spread in the 
environment due to human activities. The metal is persistent in the 
environment and the industrial use of cadmium, mainly in nickel-cadmium 
batteries and metallurgy of zinc but also in new nano-materials, results in an 
increasing risk of human exposure (Fowler, 2009).  
2.1.1  Adults 
Food constitutes the predominant source of cadmium exposure for non-
smokers and non-occupationally exposed individuals (EFSA, 2009). 
Exposure to cadmium originates mainly from intake of vegetable food since 
cadmium in the soil is readily taken up by plants (Clemens, 2006). In 
Europe more than 80% of the cadmium intake derives from cereals, 
vegetables and potatoes (Olsson et al., 2002), although the highest cadmium 
concentrations are found in oysters, chephalopods and crabs. Cadmium in 
drinking water and ambient air contribute minimally to the total exposure 
(Olsson et al., 2002; Vahter et al., 1991).  
Already in 1972 the joint FAO/WHO Expert Committee on Food 
Additives and Contaminations established a Provisional Tolerable Weekly 
Intake (PTWI) for cadmium of 7-8 g/kg body weight. Since then, several 
risk assessments concerning cadmium exposure have been conducted, but 
not until 2009 EFSA reduced the Tolerable Weekly dietary Intake (TWI) of 
cadmium to 2.52 g/kg body weight (EFSA, 2009). In Europe the exposure 
of cadmium in adults is close to the TWI, and EFSA conclude that 
subgroups such as vegetarians, children, smokers and people living in   14
contaminated areas, may have an intake as high as twice the TWI (EFSA, 
2009).      
The critical adverse health effect of cadmium is nephrotoxicity (Åkesson 
et al., 2005; Järup et al., 2000; Friberg, 1948). The renal toxicity results from 
an accumulation of cadmium in the proximal tubules causing impaired 
reabsorption of nutrients, vitamins and minerals. Cadmium is retained in the 
kidney with a biological half-life of 10-30 years (Järup et al., 1998). 
Recently it was observed that negative effects of cadmium on bone mineral 
density occur at similar low levels of exposure as for early renal effects 
(Åkesson et al., 2006; Alfvén et al., 2000). Already since 1957, high 
cadmium exposure has been known to cause both osteomalacia and 
osteoporosis (Nordberg, 2009; Hagino, 1957). The itai-itai disease is 
characterized by bone fractures and severe pain caused by decalcification of 
the bones and renal damages. In 1993, the International Agency for 
Research on Cancer (IARC) classified cadmium as carcinogenic to humans 
based on an association between cadmium exposure and increased incidence 
of lung tumors (IARC, 1993). There are also indications that cadmium 
induces kidney and prostate tumors in humans (Vinceti et al., 2007; Il'yasova 
& Schwartz, 2005). Furthermore, there is evidence that cadmium exposure 
is associated with hormone-related cancers (Åkesson et al., 2008; McElroy et 
al., 2006).  
2.1.2  Neonates 
In neonates the exposure route of cadmium is via breast milk, formula or 
complementary food. Although cadmium levels in milk are low (Floris et al., 
2000; Petersson Grawé & Oskarsson, 2000; Hallén et al., 1995; Smith et al., 
1991), neurodevelopmental effects have been seen in suckling rodent pups 
of exposed mothers. However, it is unclear whether these negative effects 
are caused by low levels of cadmium transferred via milk or by cadmium-
induced alterations in milk composition due to effects in the mammary 
gland (Petersson Grawé et al., 2004a). Observed effects are behavioral 
disturbances (Petersson Grawé et al., 2004b), altered levels of 
neurotransmitters (Andersson et al., 1997) and changes in fatty acid 
composition in the brain (Petersson Grawé et al., 2004a). These effects have 
been demonstrated at doses well below the doses that cause renal 
dysfunction in the mothers (WHO, 1992), indicating that the developing 
offspring might be more sensitive to the toxic effects of cadmium and that 
the toxic response is age-dependent. Generally, neonates are considered 
more vulnerable than adults to chemical exposure (Landrigan, 2004), mainly 
because of rapid growth and development of organs and functions.    15
2.2  Cellular cadmium metabolism 
2.2.1  Ionic mimicry by cadmium 
The chemical and physical properties of cadmium is similar to iron, zinc, 
manganese and calcium. These divalent essential metals have rigorously 
controlled uptake and metabolism, because they cannot be synthesized or 
destroyed by the cells. To enable biological actions cadmium has to use 
transport pathways for essential metals by “ionic and molecular mimicry” 
(Bridges & Zalups, 2005).  
Low status of both calcium and iron increases cadmium absorption in 
adult animals (Min et al., 2008a; Reeves & Chaney, 2002; Kello et al., 1979) 
and in adult humans (Kippler et al., 2009a; Olsson et al., 2002; Berglund et 
al., 1994). This supports the notion that the molecular toxicity of cadmium 
involves interactions with the transport pathways of these essential metals 
and is in concordance with the findings that intestinal cadmium uptake in 
mice is mediated via several different pathways for essential metals (Min et 
al., 2008a; Min et al., 2008b). There are two separate ways for absorption 
across the intestinal epithelium; the paracellular- and the transcellular route. 
The paracellular transport pathway is passive diffusion across the tight 
junctions between cells and the transcellular pathway is regularly the energy-
dependent transport across the two cellular membranes of the enterocyte, 
involving transport proteins.      
Calcium transporters and channels 
Cadmium is known to interfere with the tightly regulated levels of 
intracellular calcium by modifying the function of specific calcium 
transporters and calcium channels (Bridges & Zalups, 2005). Calcium can be 
transported paracellularly and transcellularly, mainly depending on calcium 
status (Khanal & Nemere, 2008). In individuals with normal calcium status 
the paracellular calcium transport dominates. However, during periods of 
particularly high calcium demand, e.g. lactation, or calcium deficiency, the 
absorption predominantly occurs via the transcellular pathway regulated by 
1,25-dihydroxyvitamin D and the calcium uptake transporter, transient 
receptor potential vanilloid 6 (TRPV6, former CaT1) (Khanal & Nemere, 
2008). TRPV6 is the main calcium transporter across the apical membrane 
of the intestine but is also expressed in e.g. mammary tissue (Bolanz et al., 
2008; Wissenbach & Niemeyer, 2007). 
Once inside the cell calcium binds to calcium binding proteins, such as 
calbindin and calmodulin to reduce levels of free calcium, since high 
concentrations of the unbound mineral is toxic to the cell. Calcium is,   16
besides being necessary for strong bones, a very important intracellular 
second messenger that controls a wide range of essential biological processes, 
including many signaling pathways and apoptosis in the cells. The 
endoplasmic reticulum (ER) is the main storage of intracellular calcium for 
signaling purposes. Calcium is transported into ER by sarco/endoplasmic 
reticulum calcium ATPases (SERCAs) and effluxed via inositol-1,4,5-
triphosphate receptors and ryanodine receptors (Berridge et al., 2003).  
Secretory pathway Ca-ATPase (SPCA) transports calcium into the Golgi 
apparatus where calcium is required for translation and maturation of 
secretory proteins (Wuytack et al., 2003). In the lactating mammary gland, 
calcium in Golgi is needed for phosphorylation of milk proteins (Faddy et 
al., 2008; Neville, 2005). Plasma membrane calcium ATPase (PMCA) 
mediates efflux of cytosolic calcium across the basolateral membrane of the 
intestine into the blood and across the apical membrane of the mammary 
cell into the milk (VanHouten et al., 2007; Hoenderop et al., 2000).  
Cadmium is suggested to affect calcium homeostasis by inhibiting 
SERCAs, PMCAs and voltage dependent calcium channels (Thévenod, 
2009). However, there are studies showing that cadmium stimulates, instead 
of inhibits, calcium pathways in the cell, indicating that cadmium effects on 
calcium- transporters and channels are dose-dependent. 
Iron transporters 
Epidemiological and experimental studies have shown that iron deficiency in 
adults increases the gastrointestinal absorption of cadmium (Meltzer et al., 
2010; Kippler et al., 2007; Bárány et al., 2005; Berglund et al., 1994; 
Flanagan et al., 1978). Iron absorption occurs predominantly by the 
transcellular route in the duodenum, independently of iron status. However, 
the amount of iron absorbed across the intestinal epithelium is dependent on 
iron status. Two iron transporters, divalent metal transporter 1 (DMT1) and 
ferroportin 1 (FPN1), are critical for gastrointestinal absorption of non-heme 
iron (Donovan et al., 2000; McKie et al., 2000; Fleming et al., 1998; 
Fleming et al., 1997). Ferric iron is converted to ferrous by the duodenal 
cytochrome reductase b (DCYTB) and then transported across the apical 
membrane of the enterocyte by the proton-coupled DMT1 (Andrews & 
Schmidt, 2007). Once inside the cell iron is bound to ferritin and either 
stored in the enterocyte organelles or transported across the basolateral 
membrane into the blood by FPN1. Ferrous iron is converted back to ferric 
by the protein hephaestin that is colocalized with FPN1. Ferric iron is then 
bound to transferrin, which is responsible for transporting iron in the 
circulation. The expressions of DMT1, the isoform DMT1-IRE (containing   17
an Iron Responsive Element) and FPN1 are induced by iron deficiency in 
adult humans and repressed by iron sufficiency (Nelson et al., 2010; Zoller et 
al., 2001).  
In the mammary epithelial cells both DMT1 and FPN1 are localized to 
the cytoplasm and are not present at the plasma membranes, indicating a 
different function than in the intestinal epithelial cells (Leong & Lönnerdal, 
2005). Furthermore, the study by Leong & Lönnerdal (2005) indicates that 
the regulation of DMT1 and FPN1 in the lactating mammary gland appears 
to be different from that in the intestine. The iron uptake across the 
basolateral membrane of mammary epithelial cells has instead been suggested 
to involve the transferrin receptor. Transferrin bound iron and the receptor 
undergoes endocytosis into endosomes and DMT1 localized at the 
endosomal membrane efflux iron into the cytosol. Iron can then be utilized 
by the cell or bind to iron-binding proteins, such as casein, lactoferrin and 
transferrin and then secreted by exocytosis across the apical membrane 
(Lönnerdal, 2007).  
DMT1 has been shown to transport a broad range of divalent metals in 
vitro, including cadmium, across the apical membrane of the enterocyte 
(Bannon et al., 2003; Tallkvist et al., 2001; Picard et al., 2000). There are 
also indications that FPN1 is involved in cadmium absorption in adults (Kim 
et al., 2007; Ryu et al., 2004). Taken together with the relation between 
low iron status and high body burden of cadmium, these findings implicate 
that DMT1 and FPN1 play important roles in cadmium absorption in adults. 
2.2.2  Cellular protection against cadmium 
Two major systems of cellular protection against cadmium are known; one 
involving metallothionein (MT) and the other glutathione (GSH) (Klaassen 
et al., 2009; Liu et al., 2009; Wimmer et al., 2005). Once absorbed into the 
circulation cadmium is predominantly bound to albumin, but other proteins, 
peptides and amino acids e.g. MT, transferrin and GSH can also bind the 
metal and act as carriers (Zalups & Ahmad, 2003). Cadmium is known to 
bind with high affinity to thiol (SH) groups in various peptides and proteins 
(Leverrier et al., 2007; Diaz-Cruz, 1997). However, the binding of 
cadmium to MT has higher affinity than to GSH, due to differences in 
molecular structure (Vesey, 2010). This indicates that cadmium bound to 
GSH more readily can interact with other cellular ligands and transporters 
than cadmium bound to MT.    18
Metallothionein 
Cadmium induces cellular MT, a low-molecular weight cystein-rich protein 
involved in the binding and detoxification of excessive intracellular levels of 
cadmium, zinc and copper (Klaassen et al., 2009; Nordberg & Nordberg, 
2000; Klaassen et al., 1999; Kagi & Valee, 1960). Four major isoforms of 
MTs have been identified, MT1-4. MT1 and MT2 are the ones induced 
following cadmium exposure and are highly expressed in intestine, liver, 
kidney and pancreas. There are indications that the gene expression and 
protein level of MTs often show discrepancies (Bourdineaud et al., 2006). 
MT sequesters cadmium in the cytosol and reduces the level of free 
cadmium, inhibiting the metal to damage biological proteins vital for the cell 
(Liu et al., 1993). The importance of MT in limiting cadmium toxicity has 
been proven in MT-null mice that are hypersensitive to cadmium-induced 
effects in the kidney, although they had lower cadmium concentrations in 
their tissues (Liu et al., 2000). Cadmium-MT complexes are transferred from 
the liver to the kidney where they are filtered through the glomerulus and 
reabsorbed in the proximal tubules. There are indications that cadmium-MT 
complexes enter lysosomes in the tubular cells, where they are degraded and 
free cadmium is released into the cytosol (Dorian et al., 1992; Min et al., 
1992a).  
It has been proposed that intestinal cadmium absorption may be limited 
by MT, which is synthesized in the intestinal epithelium following oral 
cadmium exposure (Kimura et al., 1998; Min et al., 1992b). However, 
studies with MT-null mice have not supported this hypothesis (Liu et al., 
2000; Liu & Klaassen, 1996), rather concluded that the impact of intestinal 
MT on cadmium absorption is of minor importance (Klaassen et al., 2009). 
MT is also induced by oxidative stress and plays an important role in the 
cellular protection against free reactive oxygen species (ROS) (Chiaverini & 
De Ley, 2010; Min et al., 2005; Klaassen et al., 1999; Thornalley & Vasak, 
1985).  
Glutathione 
The antioxidant GSH plays a fundamental role in defending the cell against 
oxidative stress and detoxification of xenobiotics. Oxidative stress or 
imbalance between generation of ROS and cellular antioxidant production 
may cause lipid peroxidation, protein modifications and DNA damage. 
Formation of ROS can also activate several intracellular signaling pathways, 
in conformity with calcium. 
Acute cadmium exposure results in a rapid reduction in GSH levels due 
to the formation of cadmium-GSH complexes. This is believed to be the   19
first protection against free cadmium in the cytosol (Singhal et al., 1987; 
Dudley & Klaassen, 1984). However, chronic exposure to the metal often 
results in elevated tissue levels of GSH (Kamiyama et al., 1995), which will 
reduce the oxidative damage caused by cadmium. Despite the fact that 
cadmium is not a redox metal, there are numerous in vivo and in vitro studies 
suggesting that the cadmium indirectly generates ROS in mammalian cells 
(Pourahmad et al., 2003; Yamano et al., 2000; Thévenod & Friedmann, 
1999). Cadmium has been suggested to induce ROS in three different ways: 
1) by displacement of redox metals bound to MT (Dorta et al., 2003); 2) by 
damaging critical cellular organelles, e.g. mitochondria (Wang et al., 2004); 
3) by a reduction and depletion of intracellular radical scavengers, such as 
GSH (L'Hoste et al., 2009; Nigam et al., 1999). Furthermore, cadmium 
exposed MT-null mice show stronger response in ROS-related gene 
expressions than wild type mice (Liu et al., 2002), supporting the hypothesis 
that MT and GSH play complementary roles in the cellular protection 
against cadmium toxicity. Cadmium may also affect antioxidant enzymes as 
cytochrome oxidase complex (COX) catalase and superoxid dismutase 
(SOD) (Cannino et al., 2009; Joseph, 2009; Badisa et al., 2008). In a recent 
long-term low dose study in mice, cadmium exposure resulted in a biphasic 
oxidative stress response showing acute induction of MTs and the 
thioredoxin gene Prdx2 (Thijssen et al., 2007). The late response included 
increase in the gene expression of several enzymes involved in eliminating 
ROS and indicated that the cells were able to adapt to the cadmium 
exposure. The thioredoxins play an important role in reducing ROS, 
together with e.g. GSH and SOD.     
ABC transporters 
The ATP-binding cassette (ABC) transporter superfamily is responsible for 
the active transport of a wide variety of compounds across biological 
membranes, including endo- and xenobiotics (Higgins, 2007). The family 
consists of seven subfamilies, including the three families: multi drug 
resistance protein permeability glycoprotein (P-gp), breast cancer related 
protein (BCRP) and multidrug resistance associated protein (MRP1-13) 
(Leslie et al., 2005). In eukaryotes all ABC-transporters are efflux proteins 
involved in cellular- and tissue protection. In addition, to induce drug 
resistance (as implicated by the name), multidrug resistance associated 
proteins and P-gp reduce the accumulation of toxic substances and are 
thereby involved in the cellular defense. MRP1 is ubiquitously expressed in 
the whole body and located at the basolateral side of most cells, where it 
transports substrates into the blood (Cole & Deeley, 2006; Cole, 1992). In   20
the intestinal epithelium the overall gene and protein expression of MRP1 is 
low (Berggren et al., 2007; Prime-Chapman et al., 2004). Despite this, 
MRP1 has been demonstrated to play a critical role in protecting the small 
intestine from toxic substances (Kato et al., 2009). MRP2 and P-gp are 
mostly expressed in tissues important for xenobiotic protection, such as 
intestine, liver blood-brain barrier and placenta, where they are located at 
the apical membrane effluxing their substrates (Haimeur et al., 2004; Kimura 
et al., 2004). MRP1 and MRP2 can actively transport GSH-complexes 
(Cole & Deeley, 2006; Dietrich et al., 2001; Mao et al., 2000) and have, in 
accordance with P-gp, broad substrate specificity to neutral and positively 
charged hydrophobic compounds (Klaassen & Aleksunes, 2010; del Amo et 
al., 2009; Zaman et al., 1995). The formation of ROS as well as altered 
levels of intracellular GSH have been suggested to regulate the gene 
expression of MRP1 (Tatebe et al., 2002; Yamane et al., 1998).  
Several ABC efflux proteins have been proposed to be implicated in 
cadmium transport and MRP1 is suggested to be the most probable 
candidate (Thévenod, 2010). It has been shown in vitro that cadmium-GSH 
complexes are transported across the basolateral membrane of enterocytes by 
MRP1 (Li et al., 1997; Tommasini et al., 1996). A recent study found that 
cells with higher cadmium resistance show increased mRNA and protein 
levels of MRP1, as well as increased activity of the transporter, indicating 
that MRP1 protects the cell against cadmium toxicity (Oh et al., 2009). The 
apical efflux proteins MRP2 and P-gp have also been demonstrated to be 
upregulated by cadmium (Huynh-Delerme et al., 2005; Terlouw et al., 
2002), suggesting that these ABC transporters may reduce cadmium uptake 
from the intestinal lumen. Furthermore, the ABC efflux protein CFTR 
(cystic fibrosis transmembrane conductance regulator), which is an apical 
chloride channel, has recently been implicated in cadmium efflux in the 
renal tubule cells (L'Hoste et al., 2009). CFTR is also localized in the apical 
membrane of enterocytes and, although not investigated, may therefore limit 
cadmium uptake from the intestinal lumen (Jakab et al., 2010).  
2.3  Lactating mammary gland 
The mammary gland is a highly specialized secretory organ that is tightly 
regulated by a complex interplay between lactogenic and steroid hormones, 
e.g. prolactin and estrogen (Lamote et al., 2004; McManaman & Neville, 
2003). Milk production and secretion is highly conserved between species, 
even though the composition of milk differs. There are five main pathways 
for secretion of milk components: 1) Exocrine pathway responsible for the   21
major milk proteins (caseins and whey) and lactose; 2) Milk lipid pathway 
secreting triglycerides in large droplets called milk fat globuli; 3) Passive 
diffusion pathway of small molecules as sodium, potassium and chloride 
across membranes into the milk; 4) Transcytotic pathway transfers 
immunoglobulins via receptors, pinocytosis and exocytosis into milk; 5) 
Paracellular pathway, though the tight junctions is closed during full 
lactation and only accessible during pregnancy or mastitis. 
Lactating mammary epithelial cells synthesize 80-95% of the proteins 
present in milk, including caseins, -lactalbumin and whey acidic protein  
(WAP). Milk proteins are secreted into the milk alveolar lumen via the 
exocrine pathway (Burgoyne & Duncan, 1998; Jensen, 1995). Lactose, 
calcium and phosphate are also partially secreted by this pathway. Milk 
proteins are implicated in numerous physiological functions of significant 
importance for the development of the suckling neonate (Lönnerdal, 2003).  
The milk protein β-casein, one of the major constituents of the casein 
family, significantly contributes to the overall nutrition of the suckling 
offspring (Lönnerdal, 2003; Jensen, 1995; Greenberg et al., 1984). Besides 
providing a source of amino acids to the developing neonate β-casein 
increases the bioavailability of calcium by forming micelles that keep the 
mineral soluble (Holt & Sawyer, 1988). The gene expression of β-casein in 
mice increases during late gestation and peaks during lactation (Robinson et 
al., 1995). Furthermore, it has been shown that calcium is required for 
synthesis and phosphorylation of β-casein (Burgoyne & Duncan, 1998; 
Duncan & Burgoyne, 1996).  
The lactating mammary gland transports as much as 400 mg of calcium 
across the mammary epithelial cells every day (Prentice, 2000). It is an 
impressive work load that the secretory mammary epithelial cells are coping 
with when mediating unidirectional transport of millimolar amounts of 
calcium from the blood ([Ca2+] = 1-3 mM) into milk ([Ca2+] = 3-8 mM) 
and at the same time maintaining cellular calcium homeostasis. The massive 
transport of calcium is tightly regulated by a range of calcium transporters 
and channels to protect the cell from calcium cytotoxicity as well as 
disturbances in cellular signaling (Shennan, 2008). The Golgi apparatus 
handles a large intracellular calcium pool and therefore it is necessary to have 
active transporters that efficiently transfer calcium into the Golgi. In an 
experimental model of mammary gland involution, Reinhardt and Lippolis 
(2009) found decreased calcium levels together with reduced expression of 
the calcium transporter SPCA, which is located in the Golgi membranes of 
mammary epithelial cells.    22
Iron transport across the mammary epithelial cells is believed to be 
mainly mediated by the transferrin receptor and released into the milk by 
exocytosis, as described above in the section about iron transporters.  
Besides accumulating in the kidney cortex cadmium has also been 
demonstrated to be retained in mammary glands of rodents (Petersson 
Grawé & Oskarsson, 2000; Bhattacharyya et al., 1982; Bhattacharyya et al., 
1981). The mammary gland retention is in line with the observation that the 
levels of cadmium in human, ruminant and rodent milk is low, indicating 
that the mammary gland partially acts as a barrier protecting the suckling 
offspring from exposure to the toxic metal (Floris et al., 2000; Petersson 
Grawé & Oskarsson, 2000; Hallén et al., 1995; Smith et al., 1991). Since 
cadmium sequesters in the mammary gland there is a risk that the metal 
disturbs the normal function of this tissue and interferes with milk synthesis. 
In accordance with this, cadmium may be a contributing factor to the 
reduced milk protein levels from mothers with high cadmium exposure 
(smokers) compared to levels detected in milk from mothers with low 
cadmium exposure (non-smokers) (Milnerowicz & Chmarek, 2005). 
Furthermore, in epidemiologic studies a negative association between 
cadmium and calcium in milk has been found (Kippler et al., 2009b; Honda 
et al., 2003). 
2.4  Neonatal intestinal epithelium 
The intestine has digestive and absorptive functions and is one of the most 
important physiological barriers protecting the neonate against exposure to 
toxic substances. During the immediate neonatal period the gastrointestinal 
tract undergoes intense growth, morphological changes and functional 
maturation. These changes are closely related to the first days ingestion of 
colostrum, which is the breast milk rich in immunoglobulins, enzymes, 
hormones, growth factors and neuroendocrine peptides (Brandtzaeg, 2010; 
Sheard & Walker, 1988).  
The crypt stem cell of the intestine differentiates into four cell types; 
enterocytes that constitutes more than 80% of the total cells, goblet cells that 
produce mucins, enteroendocrine cells and Paneth cells that secrete 
antimicrobal-, digestive- and growth factors. The enterocyte, goblet and 
enteroendocrine cells differentiate as they migrate from the crypt up to the 
villous tip, where they exfoliate from the tip into the intestinal lumen, 
within five days in the adult. The migration rate from the crypt to the 
villous tip has been demonstrated to be slower in newborn animals than in 
adult (Pacha, 2000). In newborns the gastric pH is high (6-8) compared to   23
adults (about 2) and the gastric emptying is slower reaching adult levels not 
until the age of six months. Maturation of the intestinal barrier occurs 
around gestational week 38, but continues in the neonatal period, which 
enables the newborn to absorb macromolecules (e.g. IgGs) from the milk 
(Newburg & Walker, 2007). Together with low levels of plasma proteins, 
high relative total body water and immature kidney function these age-
dependent changes generally result in increased absorption, higher amount 
of unbound substances in plasma and decreased excretion in the newborn 
(Yokoi, 2009).  
The oral absorption of cadmium is estimated to be 3-5% in the adult 
population (EFSA, 2009). However, the absorption rate of cadmium 
depends on several factors as mentioned above, including age, status of iron 
and calcium as well as body burden of cadmium (Flaig et al., 2003). Oral 
absorption rates of 20-40% have been observed in young individuals and 
infants (Horiguchi et al., 2004; Kikuchi et al., 2003; Crews et al., 2000). The 
high absorption in infants is probably due to the immaturity of the intestinal 
epithelium. In addition to a high absorption rate, infants may also a higher 
intake of cadmium per kg body weight due to specific exposure pattern.  
In neonates calcium is predominately absorbed via the paracellular 
pathway as in adults with normal calcium status (Bass & Chan, 2006). 
Several calcium transporters, as mentioned above, rigorously control the 
calcium level in breast milk and therefore the neonate is breast fed with 
sufficient amounts of calcium. In accordance, the intestinal calcium 
transporters involved in transcellular calcium transport in adults with low 
calcium status have so far not been identified in the neonatal intestine 
(Figure 2). 
Developmental changes in the intestinal absorption of iron in neonates 
have been suggested (Leong et al., 2003b; Domellöf et al., 2001). Thus, an 
epidemiologic study on breast-fed infants indicated that intestinal iron 
absorption is not regulated until 6-9 months of age (Domellöf et al., 2001), 
and studies on suckling rat pups demonstrated that iron absorption and 
expressions of DMT1 and FPN1 are not regulated until the time of weaning 
(Leong et al., 2003a; Leong et al., 2003b) (Figure 2). Instead, it is believed 
that iron absorption from milk in newborns predominantly occurs via 
receptor-mediated endocytosis of lactoferrin bound iron (Suzuki et al., 
2001).  
The expression of a majority of the ABC transporters in the neonatal 
intestine is at present not investigated. However, the expression of P-gp in 
mice has been demonstrated to be low at birth and continuously increasing 
until weaning when the P-gp expression reaches adult levels (Mahmood et   24
al., 2001). Peptide transporter 1 and apical sodium dependent bile acid 
transporter have been found to have a biphasic expression pattern with 
elevated levels at birth and again at weaning (Klaassen & Aleksunes, 2010). 
In addition, neonatal tissues generally express higher levels of MT than 
adults (Yoshida et al., 1998; Bakka & Webb, 1981). In newborn rats the 
concentration of MT is more than 10 times higher than in adult animals 
(Goering & Klaassen, 1984). Despite this, MT had no limiting effect on the 
intestinal absorption of cadmium in the newborn offspring to MT-null mice 
(Brako et al., 2003).   
 
Figure 2. Calcium, iron and ABC-transporters in enterocytes of adult (mature) (A) and 
neonatal (immature) (B) intestine. TRPV, transient receptor potential vanilloid; PMCA1, 
plasma membrane calcium ATPase 1; DMT1, divalent metal transporter 1; FPN1, ferroportin 
1; MRP2, multidrug resistance associated protein 2; P-gp, plasma glycoprotein; MRP1, 
multidrug resistance associated protein 1; GSH, glutathione; X, endogenous or exogenous 
substrate; N, nucleus; ER, endoplasmic reticulum; GA, Golgi apparatus.   25
3  Aims of the thesis 
The overall aim was to study cadmium during the neonatal period, focusing 
on intracellular transport pathways and interactions of cadmium with 
calcium and iron. In vivo and in vitro models were used to study cadmium in 
epithelial cells of two critical tissues during early life: the lactating mammary 
gland and the neonatal intestine (Table 1).  
 
 
The specific aims were to: 
 
1.  Investigate effects of cadmium in the lactating mammary glands and 
examine possible mechanisms for induced disturbances in mammary 
epithelial cells (paper I & II).  
 
2.  Determine the impact of iron status on cadmium absorption in neonatal 
intestine and examine transporters involved in cadmium transport across 
immature enterocytes (paper III & IV).    
 
 
The long-term aim was to provide new insights in cadmium toxicity during 
early life and elucidate differences in the effects of cadmium between 
newborns and adults.  
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4  Materials and methods 
This section is an overview of the methods used in this thesis. For further 
details, the reader is referred to the individual papers (I-IV). 
4.1  Experimental models 
To gain mechanistic insights into the cellular effects of cadmium in the 
lactating mammary gland and the neonatal intestine this thesis consists of a 
combination of in vivo and in vitro studies.       
4.1.1  Lactating mice (paper I & II) 
Cadmium-induced effects in the lactating mammary gland were studied by 
using lactating mice. NMRI-mice were given a standard pellet diet and tap 
water ad libitum. Litter sizes were normalized to eight on lactation day (LD) 
2 and the dams with litters were kept in individual cages (the day of 
parturition = LD 0). On LD 8 the dams and their litters were randomized 
into four dose groups, each containing six animals. On LD 8, 9, and 10 the 
dams were given subcutaneous injections of cadmium (5, 100, 2000 µg 
Cd
2+/kg body weight as CdCl2 dissolved in NaCl), whereas controls were 
given only saline. The lowest cadmium dose used is in the same magnitude 
as the PTWI value of 2.5 µg Cd
2+/kg body weight (EFSA, 2009). The two 
higher cadmium doses were chosen to examine possible dose-response 
effects. In paper II only the highest dose were used. 
Animals were euthanized in random order by CO2-asphyxiation on LD 
11 and samples of the mammary glands were dissected and stored at -70C 
pending isolation of total RNA, proteins and calcium analyses. Samples of 
the mammary glands and kidneys were also taken and fixed in 
paraformaldehyde/glutaraldehyde for histological examination. To minimize 
possible individual variations left inguinal mammary glands (4 and 5) were   28
dissected from all the 24 dams. All animal experiments were approved by 
the Local Ethics Committee of Animal Research (permit no. C 159/2). 
4.1.2  Murine mammary epithelial HC11 cells (paper II) 
The HC11 cells are non-tumorigenic and originally derived from murine 
mammary tissue taken at mid-gestation (Danielson et al., 1984). When 
treated with prolactin, cortisol and insulin the HC11 cells adopt a secretory 
phenotype resembling mammary epithelial cells in the lactating mammary 
gland, including increased β-casein gene and protein expression (Desrivieres 
et al., 2003; Ball et al., 1988).  
HC11 cells were cultured in RPMI 1640 media supplemented with fetal 
calf serum, insulin, epidermal growth factor (EGF) and gentamycin in 
polycarbonate flasks. Medium was changed every 2 or 3 days and cells sub 
cultured every 3 or 4 days. HC11 cells were seeded at a density of 1.5 x 10
5 
cells/cm
2 and two days postconfluency, the medium was replaced by serum-
free medium without EGF containing prolactin and cortisol to promote 
differentiation of the cells into a secretory phenotype and incubated for 72 
h. HC11 cells were exposed to nontoxic cadmium and /or nifedipine 
concentrations that neither affected intracellular ATP levels nor LDH 
leakage into the medium. Cells were treated with medium containing 0.006, 
0.13, or 2.5 µM cadmium; 1 or 10 µM nifedipine; 1 µM nifedipine and 2.5 
µM cadmium during the differentiation. Cells treated with medium without 
cadmium or nifedipine supplementation were used as controls. 
Cytotoxicity was assessed by the determination of intracellular ATP and 
medium lactate dehydrogenase (LDH) levels. The ATP assay is based on the 
firefly luciferase enzyme’s requirement for ATP in producing light. The 
cytosolic enzyme LDH is released in cell media upon cell lysis and is based 
on the enzyme’s capacity to convert a tetrazolium salt into a red formazan 
product. HC11 cells were differentiated in the presence of cadmium (0.8 
pM - 1 mM) (vehicle NaCl), nifedipine (125 nM - 10 µM) (vehicle 
DMSO) or cadmium+nifedipine (0.125 - 2.5 µM + 0.1 - 10 µM) for 72 h. 
Luminescence, as an indicator of intracellular ATP-levels, and absorbance at 
490 nm, as indirect LDH measurement were, measured in a multiplate 
reader.  
4.1.3  Suckling piglets (paper III & IV)  
Pigs are omnivorous with anatomical and physiological conditions of the 
gastrointestinal tract that resemble those of humans, in particular the 
duodenum is similar, but also the diet composition, gastric pH and transit 
time for food (Miller & Ullrey, 1987).    29
Purebred Yorkshire piglets (n = 32, same boar) were held indoors 
together with their respective sow. All piglets were individually tattooed 
with a number in the ear and no routine medical treatment was given. The 
animal experiments were approved by the Local Ethics Committee of 
Animal Research (permit no. C 29/5). 
Piglets in paper III were divided into eight similar blocks (four piglets per 
block) on postnatal day (PND; day of birth = 0) 2 according to the 
following criteria: litter, gender and weight. Each animal of a block was 
randomly assigned to one of the four treatments: iron deficient not given 
cadmium (C), iron supplemented not given cadmium (Fe), iron deficient 
given cadmium (Cd) and iron supplemented given cadmium (Fe+Cd). In 
paper IV one control (C) and one iron supplemented (Fe) piglets were used. 
Iron supplementation of the piglets was performed by administration of iron 
dextran intramuscularly on PNDs 3 and 14. This routine iron deficiency 
prophylaxis treatment is recommended by The Swedish Animal Health 
Service and performed on piglets in pig production. If not supplemented 
with iron, piglets become iron deficient a few days after birth, due to low 
levels of iron in the sow’s milk, in combination with the rapid growth and 
expansion of hemoglobin mass (Szabo & Bilkei, 2002). 
Cadmium exposed piglets (Cd, Fe+Cd) were orally given cadmium on 
the basis of the daily weight on PNDs 10-15 by a blunt syringe extended 
with a plastic tube directly in the pharynx. At each administration the piglets 
were given 20 µg cadmium/kg body weights solved in glycerol and piglets 
not given cadmium (C, Fe) were given equal volumes of glycerol orally. In 
between administrations, all piglets were kept with their respective sow and 
allowed to suckle. On PND 16, piglets were killed in random order by an 
intraperitoneal overdose of pentobarbital. Blood, kidney cortex, and 
duodenum samples were collected and stored at -70°C prior to cadmium 
analyses and protein isolation. Samples of the duodenum were dissected and 
fixed in formalin for immunohistochemistry. To minimize possible 
individual variations all piglets were dissected and samples taken in the same 
sequences each time.  
4.1.4  Immature human intestinal epithelial Caco-2 cells (paper IV) 
In paper IV, 7 days postconfluent human intestinal Caco-2 cells, which are 
not fully differentiated, were used as an experimental model of neonatal 
intestine (referred to as “immature Caco-2 cells”). To validate the immature 
Caco-2 cell model, barrier function, size and localizations of the nuclei and 
of iron transporters were assessed (Bravo et al., 2004; Anderle et al., 2003; 
Ma et al., 2002; McKie et al., 2000; Chantret et al., 1988). Twenty-one days   30
postconfluent Caco-2 cells, which are fully differentiated (mature), have 
been extensively used as an in vitro model of the adult human intestinal 
epithelium (Artursson et al., 2001). Under normal cell culture conditions, 
Caco-2 cells spontaneously differentiate into a phenotype that resembles 
polarized absorptive enterocytes (Artursson, 1990; Chantret et al., 1988; 
Pinto M, 1983). The Caco-2 model has been widely used to investigate 
cadmium absorption and effects (Cardin et al., 2009; Boveri et al., 2004; 
Bannon et al., 2003; Tallkvist et al., 2001; Jumarie et al., 1997). Mature 
Caco-2 cells treated with iron have reduced uptake and transport of 
cadmium that correlates to lower DMT1 levels (Tallkvist et al., 2001).  
The Caco-2 cells were expanded in normal tissue culture flasks in 
DMEM supplemented with fetal calf serum and gentamycin and seeded 
onto permeable polycarbonate filters at a density of 2.5 x 10
5 cells/filter 
support (Ø 12 mm, pore radius 0.4 μm). The Caco-2 cells were then 
allowed to differentiate for 7 days postconfluency prior to transport and 
uptake experiments, analyses of DMT1, DMT1-IRE, FPN1, MRP1, 
MRP2, P-gp and MT1 gene expressions, and DMT1, FPN1 and MRP1 
protein localizations. The medium was changed every second day and the 
cells were daily examined by reverse phase microscopy for confluency, shape 
of cells and dome formations.  
Each cell monolayer was randomly assigned to differentiate for 7 days 
postconfluency in one of the four experimental media: control (C) media or 
media supplemented with: 65 µM iron (Fe(NO3)3 x 9H2O dissolved in a 
fourfold molar excess of nitrilotriacetic acid (NTA) (Fe), 1 µM cadmium 
(CdCl2 x H2O) (Cd) and both 65 µM Fe and 1 µM Cd (Fe+Cd). 
Transport and uptake experiments were performed at 37°C, pH 7.4, in 
HBSS buffered with HEPES. Three monolayers for each experimental 
media and each radiolabeled metal were transferred to new wells where pre-
warmed HBSS was added to the apical (0.5 ml, pH 6.3, supplemented with 
L-ascorbic acid) and basolateral (1.5 ml, pH 7.4, supplemented with human 
apo-transferrin) chambers. The apical solution was either supplemented with 
30 nM 
109Cd or 20 µM 
59Fe. To determine the continuous transfer of 
109Cd 
or 
59Fe across the monolayers samples were taken from the basolateral 
chambers at 30 min intervals for 3 h and the cell monolayers were at the 
same time transferred to new wells containing pre-warmed HBSS. The 
radioactivity was measured by γ-spectrometry. To determine the apical 
uptake of 
109Cd or 
59Fe into the cells following the 3 h incubation, the filters 
with the monolayers were rinsed in ice cold HBSS and dissolved in 0.5 M 
NaOH, followed by γ-spectrometry of an aliquote of the lysate.    31
The integrity of the monolayers was controlled by determining of the 
permeability of the hydrophilic marker 
14C-mannitol, to ensure that none of 
the pretreatments used in the transport studies impaired the monolayer 
integrity.  
4.2  Experimental techniques 
Unless otherwise stated, the preparation and analyses of samples were 
performed at the Department of Biomedical Sciences and Veterinary Public 
Health, Swedish University of Agricultural Sciences, Uppsala, Sweden. 
4.2.1  Mineral and cadmium analyses (paper I-III) 
Total intracellular calcium, zinc, copper and iron 
Total cellular calcium concentrations in the mouse mammary glands (paper 
I) and HC11 cells (paper II) were determined using inductively coupled 
plasma–atomic emission spectrometry. In addition, total concentrations of 
zinc, copper and iron were measured in the mammary glands. Tissues and 
cells were digested by a mixture of 65% HNO3, 70% HClO4 and 95% 
H2SO4 and diluted with 1 M HNO3. The method used is a modification of 
an accredited (SWEDAC, Swedish Board for Accreditation and Conformity 
Assessment) in-house method. The analytical accuracy was checked against 
reference material. The sample preparation and analyses of total calcium 
concentrations were performed at SVA, National Veterinary Institute in 
Uppsala, Sweden. 
Short-term calcium fluxes 
Effects of cadmium on calcium transporters and/or channels were 
investigated in ionomycin stimulated HC11 cells using nifedipin as a positive 
control (paper II). The calcium ionophore ionomycin induces a rapid 
elevation of the intracellular calcium levels, allowing studies in short-term 
calcium fluxes. Cells were seeded in 96 well plates and two days 
postconfluency the media were removed and the cells were incubated with a 
fluorescent calcium indicator (Fluo-4). Probenecid was used to inhibit efflux 
of the indicator out of the cell during the pretreatment with Cd (2.5 μM), 
nifedipine (10 μM) or Cd + nifedipine (2.5 μM  + 10 μM) for 10 min. 
Ionomycin (10 μM) was added at time 0. Fluorescence was measured at 485 
nm (excitation) and at 535 nm (emission) with a multiplate reader at time 0 
(background fluorescence measurement F0) and then at 20 sec intervals for 
250 sec. The changes in fluorescence where analyzed as a function of time   32
and expressed as (F-F0)/F0 x 100 (%), where F-F0 denotes the change in 
fluorescence occurring during ionomycin stimulation and F0 represents the 
fluorescence level of cells before stimulation (time 0).  
Cadmium concentrations 
The concentrations of cadmium in piglet whole blood, kidney and iron 
supplements were determined by inductively coupled plasma-mass 
spectrometry (paper III). The blood samples were prepared and analyzed 
according to Bárány et al. (1997). The kidney samples were acid digested in 
concentrated nitric acid and diluted with deionized water. The cadmium 
concentration in the iron dextran supplement (Pigeron vet) was below the 
detection limit (30 ng cadmium/l). The analytical accuracy was checked 
against reference material. The sample preparation and analyses were 
performed at Lund University Hospital, Sweden. 
4.2.2  Gene expression (paper I, II & IV) 
Total RNA from lactating mammary glands was isolated by the use of 
TRIzol reagent (paper I) and from HC11 and Caco-2 cells by NucleoSpin 
RNA II kit containing Dnase I (paper II & IV). The integrity of the RNA 
was confirmed by agarose gel electrophoresis and quantification of the RNA 
was performed with the RNA specific Quant-iT RiboGreen protocol. 
Gene expressions were normalized to total RNA.  
Quantification of gene expressions of the proteins presented in Table 2 
were performed by real-time RT-PCR using Mastermix for SYBR Green I 
(paper I) and QuantiTect SYBR Green RT-PCR (paper II & IV) reagents. 
Primer concentration was 0.4 µM and 200 or 500 ng total RNA was used as 
template. Gene-specific primers for mouse β-casein, α-lactalbumin, WAP 
and SPCA2 (paper I & II) and human DMT1, DMT1-IRE, FPN1, MRP1, 
MRP2, P-gp and MT1 (paper IV) were designed by using NCBI primer 
designing tool or Primer3 and all PCR products were sequenced and blasted 
against the mouse or human genome (Table 2). In the analyses five known 
concentrations of the primer-specific cDNA, and a non-template control 
served as internal controls. Melt curve analysis was performed for each 
sample to check the specificity of the obtained PCR products. Relative 
quantification of mRNA expressions was performed by comparing the 
threshold cycle (Ct) between controls and treated cells according to the 2
-
(ΔCt)-method (Livak & Schmittgen, 2001). Fold differences were calculated 
setting untreated control to one. 
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Table 2. Primer sequences used for quantitative real-time PCR 
Primer  Oligo sequence  NCBI GenBank 
Accession No.  
Product 
size (bp) 
β-casein forward  5´-CTTAACCCCACCGTCCAAT-3´  NM_009972 143 
β-casein reverse  5´-AGCATGATCCAAAGGTGAAAA-3    
-lactalbumin forward  5´-TGATGCATTTCGTTCCTTTG-3  NM_010679 148 
-lactalbumin reverse  5´-AAAACACAGGCCCATTCAAG-3    
WAP forward  5´-TATCATCTGCCAAACCAACG-3´  NM_011709 185 
WAP reverse  5´-GGTCGCTGGAGCATTCTATC-3    
SPCA2 forward  5´-ACTCCGGCACATGCTCGCAC-3´  NM_026922 149 
SPCA2 reverse  5´- CGCATGGCTCCACTTCGCCT-3´    
DMT1 forward  5´-CGTGGCGGATTGCAGGAGGA-3´  NM_001174126 124 
DMT1 reverse  5´-ACGCTGACCACAGCAGCCAC-3´    
DMT1-IRE forward  5´-GCCATCAGAGCCAGTGTGTTTCT-3´  NM_001174125 198 
DMT1-IRE reverse  5´-TGTCAGCTTTTCAAAGATCCCACC-3´    
FPN1 forward  5´-CGAGATGGATGGGTCTCCTA-3´  NM_014585 219 
FPN1 reverse  5´-GGCTACGTCGAAAATGTGGT-3´    
MRP1 forward  5´-GCAAATCCAGGAGACAGCTC-3´  NM_004996 113 
MRP1 reverse  5´-TGATGTGCCTGAGAACGAAG-3´    
MRP2 forward  5´-CTGGTTGGGAACCTGACTGT-3´  NM_000392 172 
MRP2 reverse  5´-CAACAGCCACAATGTTGGTC -3´    
P-gp forward  5´-GCTGTTAAGGAAGCCAATGC-3´  NM_000927 120 
P-gp reverse  5´-AGCAATGGCGATTCTCTGTT-3´    
MT1 forward  5´-GCAAATGCAAAGAGTGCAAA -3´  NM_005946 213 
MT1 reverse  5´-ATGGGTCAGGGTTGTATGGA -3´      34
4.2.3  Protein expression and localization (paper II, III & IV) 
Western Blot 
Microsomal proteins were isolated from mouse mammary gland and total 
proteins from piglet duodenum. Frozen tissues were homogenized in Tris-
HCL (mammary) and Ripa lysis buffer (duodenum) containing protease 
inhibitors. The mammary homogenate was sedimented at 6 500 x g for 20 
min to remove intact cells, nuclei and mitochondria. To obtain the 
microsomal fraction the resulting supernatants were centrifuged at 140 000 x 
g for 90 min. Duodenum homogenate was incubated 30 minutes on ice and 
centrifuged at 16 000 x g for 30 minutes to remove insoluble materials. 
Microsomal fraction and total protein concentrations were quantified using 
the bicinchoninic acid (BCA) protein assay.  
The SPCA protein expression in mouse mammary tissue, and DMT1, 
FPN1 and MT protein expressions in piglet duodenum were quantified 
with Western blots. Aliquots of mammary microsomes and piglet duodenum 
proteins were separated by SDS-PAGE. Separated microsomes and proteins 
were transferred to nitrocellulose membranes, and equal loading and transfer 
was confirmed by Ponceau S staining. Membranes were blocked followed 
by primary antibody incubation SPCA, DMT1, FPN1 or MT. Horse-
radish-peroxidase-conjugated secondary antibodies were applied to the 
membranes and detected by chemiluminecence. Intensities of obtained 
bands were quantified by the Chemi-Doc Gel quantification System and the 
background subtracted. The expression of SPCA, DMT1, FPN1 and MT 
was normalized to the protein expression of tubulin.  
Immunohistochemistry  
Mouse mammary gland tissues and kidneys (paper I) were dissected and 
fixed in paraformaldehyde containing glutaraldehyde. Fixated tissues were 
either stained with toluidine blue or hematoxylin–eosin. Mammary glands 
stained with  toluidine blue  were post-fixated  in  OsO4. The mammary 
tissues were first dehydrated in ethanol and then in acetone prior to 
embedding in Agar 100 resin. Multiple 1 µm sections  were taken from each 
mammary gland and then stained. The hematoxylin–eosin stained mammary 
glands and kidneys were paraffin embedded and multiple 5 µm sections were 
taken and stained.   
Sections of piglet duodenum (paper III) and Caco-2 cell monolayers 
(paper IV) were fixed in formalin and stored in ethanol before dehydration 
and embedding in paraffin. Multiple sections <5 µm were taken of the   35
duodenum and cell monolayers and used for immunohistochemistry of 
DMT1, FPN1, MT (paper III) and MRP1 (paper IV). Unstained paraffin 
sections of piglet duodenum and cell monolayers were deparaffinized in 
xylen and antigen retrieval was performed in citrate buffer and endogenous 
peroxidase activity in tissues was blocked with H2O2. Sections were blocked 
in normal goat serum and incubated with primary antibodies. The DMT1 
antibodies used recognize both DMT1 and the isoform DMT1-IRE (Leong 
et al., 2003b). Sections were then incubated with secondary antibodies and 
avidin-biotin peroxidase complex was applied and immunoreactivity was 
detected with 3,3-diaminobenzidine staining.  
4.3  Statistical analysis 
Non-parametric methods were used in paper I & II, since the data showed 
evidence of not being normally distributed. Kruskal-Wallis test was applied 
for detecting differences between the experimental groups and Wilcoxon 
Mann-Whitney Rank-sum test for verifying differences between pair of 
groups. Jonckheere-Terpstra’s test (Lehmann, 1975) was applied for 
examining possible dose dependent relationships between the four different 
dose groups. Spearman Rank Correlation was used to assess the monotone 
correlation between β-casein expression and calcium levels.  
Parametric methods were used in paper III & IV. We tested data for 
homogeneity of variances by Bartlett’s test. In accordance with the test 
results the cadmium levels in blood and kidney (paper III) and transport 
values on cadmium and iron were log transformed before analysis. A general 
linear model (GLM) was used to investigate the effects of cadmium and iron 
and their interaction on the dependent variables followed by Tukey’s test to 
determine pairwise differences between means. Pearson’s correlation was 
used to assess the linear correlation between cadmium concentration in 
kidneys and blood.   36
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5  Results and discussion 
This section contains the main results obtained in this thesis, including 
unpublished figures comparing in vivo and in vitro results. For further details, 
the reader is referred to the individual papers I-IV. 
5.1  Cadmium effects in the mammary epithelium (paper I & II) 
Little is known about the effects of cadmium on the physiological function 
of the mammary gland. However, there  has previously been reported that 
cadmium affects fatty acid composition of rat milk (Petersson Grawé et al., 
2004a) indicating that cadmium retained in the lactating mammary tissue 
may interfere in various intracellular processes. 
The aim was to investigate possible effects of cadmium on the lactating 
mammary gland by using a model of lactating mice (paper I). To further 
examine the mechanism behind the cadmium-induced disturbances in the 
mammary gland an in vitro model of murine mammary epithelial HC11 cells 
was used (paper II). 
5.1.1  Histology (paper I) 
Cadmium exposure to mice during peak lactation resulted in histological 
changes in the mammary gland. The histological examination of the control 
mammary glands taken at LD 11 showed features characteristic of peak 
lactation. Thus, the alveolar epithelium had a flattened morphology and 
milk fat globules present in the alveolar epithelial cells and in the alveolar 
milk lumen (Figure 3A). Large quantities of fat were observed in the 
mammary glands of the dams exposed to 2000 g cadmium/kg body weight 
compared  to  controls where only minute amounts was observed (Figures 
3A and 3D). The fat content in mammary tissues tended to be increased in 
the dams exposed to 5 and 100 g  cadmium/kg body weight as compared   38
to controls at LD 11 (Figures 3A–C). The structure of the cadmium-
exposed mammary glands was generally denser and the alveolar milk lumen 
appeared reduced. Thus, a remodeling of the tissue with massive quantities 
of fat and degenerated alveolar epithelial cells was seen, typical of non-
lactating mammary glands. Similar morphological changes normally occur at 
the time of weaning when the mammary gland involutes from a lactating to 
a resting phenotype. Although this effect was most prominent in the animals 
exposed to the highest cadmium dose similar morphological alterations were 
indicated at the low and intermediate doses (Figures 3B–D). No histological 
alterations in the kidneys of cadmium-exposed dams were observed. 
 
Figure 3.  Representative histological sections of mouse mammary tissue at LD 11 of dams 
exposed to cadmium on LD 8, 9 and 10. (A) 0 (control); (B) 5; (C) 100; (D) 2000 g Cd/kg 
body weight. AE, alveolar lumen; AML, alveolar milk lumen; FG, fat globule. Magnification: 
400X. 
5.1.2  Mineral levels and short-term calcium fluxes (paper I & II) 
The total calcium concentration in the mammary glands of the dams 
exposed to 2000 μg cadmium/kg body weight was reduced with about 50%   39
compared to the control (p = 0.01) (Figure 4A). No other significant 
differences in the total concentrations of calcium, zinc, iron and copper in 
the mammary tissue were detected among the cadmium dose groups. Total 
intracellular calcium levels were also decreased approximately 20% in the 
HC11 cells following cadmium treatment (Figure 4B). 
To further study if cadmium affects calcium transporters and/or channels 
in secreting mammary epithelial cells, short-term intracellular calcium fluxes 
were investigated in the HC11 cells. The calcium ionophore ionomycin was 
used to induce a rapid elevation in intracellular calcium levels to be able to 
study cadmium effects on short-term calcium fluxes. Cells were pretreated 
with cadmium and/or the antagonist of L-type voltage-dependent calcium 
channels nifedipine (used as a positive control) and then stimulated with 
ionomycin. Pretreatment of the HC11 cells for 10 min with 2.5 µM 
cadmium resulted in a 20% reduction of the ionomycin stimulated cellular 
calcium elevation during the entire measurement interval (0-250 sec). 
Pretreatment with 10 µM nifedipine reduced the ionomycin stimulated 
calcium elevation initially by about 80% during the first 120 sec and then by 
about 50% during the remaining of the measurement interval. Combined 
pretreatment of the HC11 cells with 2.5 µM cadmium and 10 µM 
nifedipine resulted in an 80% reduction of the ionomycin stimulated calcium 
elevation that lasted throughout the measurement period. 
Thus, the results demonstrate that cadmium inhibits ionomycin 
stimulated calcium elevation in the HC11 cells and that this inhibition is 
augmented by nifedipine. Whereas nifedipine blocks L-type voltage-
dependent calcium channels in the plasma membrane, cadmium affects 
cellular calcium availability by unspecific blocking/binding of calcium 
transporters and channels in the plasma membrane as well as at intracellular 
sites (Thévenod, 2009; Bridges & Zalups, 2005; Palade et al., 1989). In a 
study by Palade et al. (1989) it was shown that cadmium but not nifedipine 
inhibits the inositol-triphosphate receptor induced calcium release from the 
ER. This suggests that the combined effect by cadmium and nifedipine to 
decrease the stimulated intracellular calcium elevation in the HC11 cells may 
in part be due to differences in sites of action. 
5.1.3  β-casein (paper I and II) 
Cadmium exposure reduced β-casein expression in a concentration 
dependent manner in the lactating mammary gland at LD 11 (p = 0.009) 
(Figure 4C). Based on the observations that neither of the cadmium doses 
altered the -lactalbumin gene expression or the histology of the maternal   40
kidneys, the reduced β-casein expression cannot be explained by a 
mechanism that involves general toxicity of cadmium in the dam. 
A negative concentration dependent relationship was also detected in the 
HC11 cells between cadmium concentrations and β-casein mRNA levels, 
demonstrating that cadmium affects β-casein expression at the cellular level 
in the mammary epithelial cells and not via cadmium-induced alterations in 
the levels of systemic mediators (Figure 4D). None of the cadmium 
concentrations used affected the intracellular ATP levels, LDH leakage or 
WAP mRNA levels in the HC11 cells, and the reduced β-casein expression 
can therefore not be explained by general toxicity of cadmium. To examine 
if the cadmium-mediated reduction in β-casein expression was related to an 
effect on cellular calcium homeostasis, nifedipine was applied. Similar to the 
effect of cadmium a significant concentration dependent reduction in β-
casein gene expression was observed following treatment with nifedipine. In 
addition, a potentiation of the reduction of β-casein gene expression was 
detected as a result of co-treatment with cadmium and nifedipine. 
Interestingly, it can be noted that the β-casein mRNA levels correlated well 
to the effects on short term calcium fluxes caused by cadmium and 
nifedipine individually as well as in combination. Consequently, one may 
speculate that the initial decrease in cell calcium concentrations is related to 
the reduced β-casein gene expression 72 h later. 
A positive association was demonstrated between β-casein expression and 
total calcium levels in  the  mammary  glands of mice exposed to cadmium 
during lactation (p = 0.011). Similar correlation has earlier been reported in 
milk from various species, the highest casein content being present in milk 
from species with the highest concentrations of total calcium (Jenness, 
1979). A possible explanation for the reduced β-casein expression might be 
that cadmium interferes with the entry of calcium into the mammary cells or 
intracellular stores. Previous investigations have indicated that the synthesis 
of β-casein is calcium-dependent (Burgoyne & Duncan, 1998), and it is well 
known that cadmium is able to disturb the tightly regulated levels of 
intracellular calcium by blocking calcium-channels and/or binding to 
calcium transporters in various tissues (Bridges & Zalups, 2005).  
5.1.4  Calcium transporter SPCA (paper II) 
The protein expression of the calcium transporter SPCA was reduced by 
about 55% in the mammary glands of the lactating dams given cadmium 
(Figure 4E). Calcium secretion into milk by mammary epithelial cells is of 
fundamental importance and secretory pathway Ca-ATPase, SPCA, is a key 
protein in this process. SPCA protein is upregulated in the mammary gland   41
during late gestation and the abundance of this calcium transporter increases 
as lactation progresses, indicating its importance in milk synthesis (Reinhardt 
& Horst, 1999). SPCA, which is located at the membranes of the Golgi, 
mediates active transport of calcium into the organelle, where it is essential 
for synthesis of caseins, including β-casein (Burgoyne & Duncan, 1998; 
Duncan & Burgoyne, 1996). We also observed a 20% reduction of SPCA 
gene expression in secreting mammary epithelial HC11 cells treated with 
cadmium for 72 h, demonstrating that cadmium affects SPCA expression at 
the transcriptional level in the mammary epithelial cells, either directly or 
indirectly via a decreased calcium level (Figure 4F).    42
 
Figure 4. Comparison between in vivo (A, C & E) and in vitro (B, D & F) results on total 
intracellular calcium levels (A & B), cadmium concentration dependent reduction in β-casein 
expression (p  0.01) (C & D) and SPCA expression (E & F). All data represents mean  SD; 
n = 6 (A & C), n = 2 T25 culture flasks (B), n = 3-7 (D), n = 4 (E), n = 8 (F); *p  0.05.      43
5.1.5  Summary (paper I & II) 
The combined in vivo and in vitro results demonstrate that cadmium disturbs 
the function of the lactating mammary gland by interfering with the tightly 
regulated calcium homeostasis in the mammary epithelial cells and that one 
of the mechanisms involves effects on SPCA (Figure 5).  
Cessation of milk synthesis occurs naturally in the lactating glands of 
rodents at the time of weaning (~ LD 21) when the suckling pup turns to 
solid food. In a study where pups were separated from the lactating dams at 
LD 12, calcium concentrations were reduced by 50% and SPCA expression 
decreased, as a result of a cessation of milk synthesis caused by forced 
weaning (Reinhardt & Lippolis, 2009). The downregulation of SPCA may 
reflect the reduced requirement for calcium in the Golgi apparatus where 
the major secretory milk protein β-casein is formed. In line with this, our 
results show that calcium concentrations were reduced by 50% as well as the 
expression of SPCA in the lactating mammary glands of mice exposed to 
cadmium. A remodeling of the mammary tissue, including increased amount 
of fat and a more condensed appearance of the milk alveoli was observed in 
the mice following cadmium exposure. Similar histological alterations 
normally occur in the mammary gland during the involution at the time of 
weaning. Furthermore, decreased concentrations of total calcium and SPCA 
expression were detected in the HC11 cells treated with cadmium for 72 h. 
Hence, the cadmium-induced effects on calcium levels and SPCA 
expression in the mammary epithelium resemble the effects observed in the 
mammary glands as a result of weaning. Irrespective of whether the lactating 
dams are exposed to cadmium or separated from their pups during peak 
lactation similar alterations in mammary epithelial calcium levels can be 
observed that coincide with a reduced SPCA expression.  
Our results provide evidence that the reduced SPCA and β-casein 
expression in mammary cells treated with cadmium is related to a reduced 
availability of cellular calcium. In addition to reducing total intracellular 
calcium levels, cadmium also disturbed the short-term calcium fluxes in 
ionomycin stimulated HC11 cells.    44
 
Figure 5. Proposed mechanism for the cadmium-induced disturbances in the mammary 
epithelial cell. Panel A showing a schematic normal milk producing mammary epithelial cell 
and panel B a schematic cadmium exposed mammary epithelial cell. SPCA, secretory 
pathway calcium ATPase; N, nucleus; ER, endoplasmic reticulum; GA, Golgi apparatus.   45
 
5.2  Cadmium effects in the neonatal intestinal epithelium (paper 
III & IV) 
The gastrointestinal uptake of cadmium has been found to be higher in 
newborns than in adults, but the reason is not fully understood (Eklund et 
al., 2001; Crews et al., 2000). It is well known that there is a strong 
correlation between low iron stores and an increased absorption of cadmium 
(Meltzer et al., 2010; Bárány et al., 2005; Åkesson et al., 2002; Olsson et al., 
2002; Berglund et al., 1994; Flanagan et al., 1978; Valberg et al., 1976) and 
there are indications that the major iron transporters DMT1 and FPN1 are 
involved in this process (Kim et al., 2007; Ryu et al., 2004). However, these 
studies were performed in adults and adolescents and not in suckling 
newborns. Our aim was to investigate cadmium absorption in neonates with 
different iron status, by applying a model of suckling piglets (paper III). To 
further examine the mechanism behind the cadmium absorption in the 
neonatal intestine we used an in vitro model of immature human intestinal 
epithelium (immature Caco-2 cells) (paper IV). 
5.2.1  Cadmium transport (paper III & IV) 
The cadmium-exposed piglets in our study had a mean concentration of 108 
ng Cd/l in whole blood. This concentration is lower than the cadmium 
levels in human infants (400 ng Cd/l) reported by Krachler et al. (1999). 
The cadmium dose used in the present study was thus realistic and did not 
affect the growth or health of the piglets. The hemoglobin levels in the 
iron-deficient piglets were lower than in the ones supplemented with iron 
from PND 7 and throughout the experimental period. Iron supplementation 
increased the serum iron concentrations at PND 15. Cadmium exposure did 
neither affect hemoglobin nor serum iron levels. 
In the iron-supplemented piglets given cadmium (Fe+Cd), the blood 
concentrations of cadmium tended to be higher (127 ± 58 ng/l) (mean ± 
SD) than in the iron-deficient piglets given cadmium (Cd) (89 ± 25 ng/l), 
although the difference was not significant (Figure 6A). Cadmium levels in 
the blood were below the detection limit in piglets not given cadmium (C 
and Fe). In the kidneys, a significant two-fold increase in cadmium levels 
was observed in the iron-supplemented piglets given cadmium (Fe+Cd) (42 
± 25ng/g ww), as compared to the iron-deficient piglets given cadmium 
(Cd) (17 ± 9 ng/g ww) (Figure 6B). No difference in kidney cadmium   46
concentrations was detected in the two groups of piglets not given cadmium 
(C and Fe). A positive and statistically significant correlation between 
cadmium levels in kidneys and blood was observed (r = 0.87, p < 0.001). 
We found no evidence that iron deficiency increases the intestinal 
absorption of cadmium in suckling piglets. In contrast, there are indications 
that iron supplementation to suckling newborns leads to an increased 
absorption of cadmium, as measured by cadmium levels in kidneys, which 
reflects an accumulated effect of cadmium exposure. The reason for the 
discrepancy between our results in newborns and previous reports in adults 
probably involves developmental changes in the handling of iron and 
cadmium. 
The transport of cadmium across the immature Caco-2 monolayers was 
increased by 170% in cells pretreated with Cd and by 270% after treatment 
with Fe+Cd compared to untreated control cell monolayers. Compared to 
the treatment with only Cd, the cadmium transport seemed to be higher in 
cells treated with Fe+Cd, although the difference was not statistically 
significant (Figure 6C). Cd pretreatment increased the transport of iron 
across the monolayers by 20%. Pretreatment with only Fe did neither 
influence cadmium nor iron transport across the cell monolayers. The 
passive diffusion of the paracellular marker mannitol was not increased, 
showing that the augmented cadmium transport was not due to disrupted 
tight junctions. 
Cadmium uptake into the Caco-2 cells was reduced by approximately 
20% compared to the controls in all pretreated groups. The uptake of iron 
into the cells was significantly affected both by Fe and Cd pretreatment. Fe 
pretreatment reduced iron uptake by 31% compared to controls, whereas 
Cd pretreatment increased iron uptake by 31%. Interestingly, we observed 
an increased iron uptake in immature cells pretreated with cadmium. The 
mechanisms behind this effect are not known. The pretreatment with 
Fe+Cd did not influence the iron uptake. 
5.2.2  Iron transporters (paper III & IV) 
No quantitative differences were observed in DMT1 or FPN1 protein 
expression due to iron status or cadmium exposure, although higher 
intestinal cadmium absorption was found in the iron-supplemented piglets. 
This indicates that another mechanism may be operative for the absorption 
of cadmium in the duodenum of the newborn. In human infants, there are 
indications that iron regulation is immature at young age (Domellöf et al., 
2001). Thus, between 4 and 6 months of age, iron supplementation 
increased hemoglobin in an unregulated manner, and not until 6–9 months   47
the effect of iron supplementation on hemoglobin was as expected 
(Domellöf et al., 2001).  
We were not able to detect any differences in localization of DMT1 and 
FPN1 among the four experimental groups and thus, the increased cadmium 
uptake in the piglets cannot be explained by differences in cellular 
localization of the iron transporters. The localizations of DMT1 and FPN1 
in the duodenal villous epithelium were in concordance to what has been 
described previously in adults; DMT1 both in the apical membrane and in 
the cytosol and FPN1 in the basolateral membrane of the absorptive 
enterocytes (Zoller et al., 2001; Canonne-Hergaux et al., 1999). It has been 
suggested that iron absorption from milk in the newborn occurs via 
receptor-mediated endocytosis of lactoferrin bound iron (Suzuki et al., 
2001). However, because it has been demonstrated that lactoferrin does not 
affect the absorption of cadmium (Mata et al., 1996), it is unlikely that the 
increased cadmium absorption observed in the iron-supplemented piglets 
involves this iron binding milk protein.  
In the immature Caco-2 cells we also included the DMT1-IRE isoform 
of DMT1 containing an iron responsive element. The in vivo results were 
confirmed in the Caco-2 immature cells and no effects on mRNA levels of 
the iron transporters DMT1, DMT1-IRE and FPN1 were observed after 
iron treatment. The gene expressions of both DMT1 and DMT1-IRE were 
reduced in the Caco-2 cells pretreated with Fe+Cd. 
The results demonstrate that the uptake of cadmium and iron into the 
iron-loaded immature Caco-2 cells does not correlate to the gene expression 
of DMT1 or DMT1-IRE. Nevertheless, iron pretreatment reduced iron 
uptake in the immature cells, indicating the presence of other iron regulated 
mechanisms. A reduced cadmium uptake into iron-loaded cells was also 
detected, which may reflect that cadmium and iron shares non-DMT1 
mediated transport mechanisms across the apical membrane of immature 
enterocytes.  
The cellular localization of DMT1 and FPN1 in the immature Caco-2 
cell monolayers did not differ among the experimental groups. Both the 
DMT1 and FPN1 staining was only detected intracellularly and the staining 
was diffuse and homogeneous within the partially differentiated Caco-2 
cells. This is in accordance with the localization in suckling rat pups at 
lactation day 10 (Leong et al., 2003b). There are indications that the 
localization of DMT1 and FPN1 in the duodenum is age-dependent. Leong 
et al. (2003b) have demonstrated that DMT1 and FPN1 expressions in 
suckling rats were not affected by iron supplementation at lactation day 10. 
The expressions of the iron transporters were not significantly decreased in   48
the iron-supplemented pups until lactation day 20. This indicates that the 
regulation of iron homeostasis is immature during early infancy and that 
there may be other mechanisms for intestinal iron absorption in the 
newborn. 
5.2.3  ABC transporters (paper IV) 
The MRP1 gene expression in immature Caco-2 cells pretreated with Cd 
increased 55% and the expression in the cells pretreated with Fe+Cd 
increased 70%. Cells pretreated with Fe showed a tendency of increased 
MRP1 gene expression compared to controls, although the difference was 
not significant. Thus, pretreatment of immature Caco-2 cells with cadmium 
causes an upregulation in the gene expression of the basolateral transporter 
MRP1, which correlated to an increased cadmium transport across the 
monolayers (Figure 6D). Cadmium is known to bind with high affinity to 
the thiol (SH) groups in GSH (Diaz-Cruz, 1997) and the complex can be 
transported by MRP1 (Li et al., 1997; Tommasini et al., 1996). The gene 
expression of MRP1 is shown in vitro to be regulated by intracellular ROS 
and GSH levels (Yamane et al., 1998). Therefore it is possible that 
cadmium-induced oxidative stress and altered GSH levels may induce 
MRP1 expression. Indeed, MRP1 has been demonstrated to be involved in 
the protection against cellular cadmium toxicity by mediating export of 
cadmium-GSH conjugates (Oh et al., 2009). Cadmium treatment decreased 
the thiol content by 65% in Caco-2 cells differentiated for 7 days, while in 
mature Caco-2 cells no difference in thiol content was observed (Cardin et 
al., 2009), indicating developmental changes in the cell defense against 
cadmium-induced oxidative stress. Immature enterocytes may be more 
sensitive than mature cells to cadmium-induced oxidative stress. We suggest 
that pretreatment of immature Caco-2 cells with cadmium or cadmium plus 
iron induces the formation of cadmium-GSH complexes, which will have a 
facilitated transport across the basolateral membrane by the upregulated 
MRP1. 
Surprisingly also an increased iron transport across immature Caco-2 cells 
pretreated with cadmium or cadmium plus iron was observed, which did 
not correlate to FPN1 expression. Cadmium-induced MRP1 may explain 
also the increased iron transport. It has previously been reported that MRP1 
is involved in the transport of iron complexes across cell membranes (Watts 
et al., 2006).  
MRP1 was detected in both control and iron supplemented piglet 
enterocytes with an intense and granular staining of MRP1 protein on the 
basolateral side of the nucleus. Iron supplementation did not affect cellular   49
localization of MRP1 protein. Similar localization of MRP1 protein has 
been demonstrated in human intestinal epithelium from adults (Blokzijl et 
al., 2008). Even though MRP1 is not present at membranes, the granular 
staining indicates that this ABC transporter mediates influx into vesicles that 
in turn are exported across the basolateral membrane of the cells. Indeed, it 
has been shown that MRP1 is involved in vesicular transport of various 
substances, such as doxorubicin and cobalamin (Beedholm-Ebsen et al., 
2010; Rajagopal & Simon, 2003).  
The cellular localization of MRP1 in the Caco-2 cell monolayers did not 
differ among the four experimental groups. MRP1 protein was found 
intracellularly and around the nuclei with no apparent plasma membrane 
staining. The MRP1 staining was granular and spotty compared to DMT1 
and FPN1 staining. This is in accordance with previous findings in mature 
Caco-2 cells (Cummins et al., 2001).  
The MRP2 and P-gp mRNA levels were not significantly affected by 
any pretreatments, even if there was a tendency of upregulation of P-gp after 
pretreatment with Fe+Cd. Cadmium uptake into the Caco-2 cells was 
decreased by Cd pretreatment. This finding may be related to the tendency 
of increased gene expression of the apical efflux protein P-gp. The reduced 
cadmium uptake in the Cd treated immature cells did not correlate to the 
transport of the metal into the basolateral chamber. However, it should be 
noted that the amount of cadmium transported across the cells only 
constitutes a minor fraction of the total uptake of the metal. Hence, even if 
the intracellular cadmium levels are decreased there is still enough of the 
metal for e.g. MRP1 to efflux out of the cell.  
5.2.4  Metallothionein (paper III & IV) 
The Western blot analysis did not reveal any differences in quantitative MT 
expression in the duodenum of suckling piglets among any of the four 
experimental groups. However, the cellular localization of MT protein 
differed between piglets exposed to cadmium and none exposed piglets. In 
the cadmium-exposed piglets (Cd and Fe+Cd), MT was localized in the 
villous epithelium and the MT staining was most pronounced at the upper 
part of the villous. In addition, a diffuse MT staining was observed on the 
serosal side of the intestinal epithelium in the cadmium-exposed piglets. In 
the piglets not given cadmium, MT was mainly localized in the crypt 
epithelium, where it presumably functions to recruit various essential metals, 
such as zinc and copper, for biochemical processes in the differentiating cells. 
Thus, iron status did not affect the quantitative MT expression or cellular   50
localization of the protein. Apparently, the increased cadmium absorption in 
the iron-supplemented piglets cannot be explained by involvement of MT.  
Gene expression of MT1 in immature Caco-2 cells was increased 30 
times after cadmium pretreatment (C: 1.0 ± 0.1; Fe: 0.8 ± 0.02; Cd: 31.5 ± 
2.1; FeCd: 28.3 ± 0.9; mean ± SEM; n = 3). Despite the strong induction, 
in vivo studies have demonstrated that MT only plays minimal roles in the 
gastrointestinal absorption of cadmium, though the retention of the metal in 
other tissues is MT-dependent (Klaassen et al., 2009). Accordingly, uptake of 
cadmium in the immature Caco-2 cells pretreated with the metal was 
significantly reduced, indicating that MT is not involved in the retention of 
cadmium in neonatal enterocytes. On the other hand, the transport of 
cadmium across the immature cells was associated with increased MT 
expression following cadmium treatment. Although not investigated, it 
might be possible that cadmium-MT complexes are transported across the 
basolateral membrane. However, at present there is no consensus regarding 
the mechanism for the possible export of cadmium-MT complexes out of 
intestinal cells.  
The strong increase in MT mRNA level after cadmium pretreatment of 
the immature Caco-2 cells, may be related to increased oxidative stress. 
Previously, a 5-fold increase in MT expression has been reported after long 
term cadmium treatment of mature Caco-2 cells (Blais et al., 1999), 
indicating that the immature cell is more sensitive to the cadmium 
pretreatment and therefore induces MT expression more strongly. In 
concordance, Cardin et al. (2009) demonstrated a higher induction of MT in 
immature Caco-2 cells compared to mature ones.    51
 
Figure 6. Cadmium absorption in suckling piglets (A & B) and cadmium transport across 
Caco-2 cell monolayers (C). The boxes are defined by the upper and lower quartiles and 
with the medians marked by a subdivision of the boxes. The highest and lowest observations 
are indicated by the whiskers that extend from the top and bottom of the boxes; n = 6; *p  
0.05 (A-C). Panel D show the positive association between MRP1 gene expression and 
cadmium transport across immature Caco-2 cells (Diamond: C; Square: Fe; Circle: Cd; 
Triangle: Fe+Cd). Data are presented as mean  SEM; n = 3 (MRP1); n = 6 (
109Cd 
transport) (D). 
5.2.5  Summary (paper III & IV) 
The combined in vivo and in vitro results indicate that cadmium absorption in 
the neonatal intestine involves the basolateral efflux protein MRP1 and that 
iron supplementation does not restrict the absorption of the metal in 
newborns (Figure 7).    52
Neonates are more sensitive to cadmium than adults, due to the 
interference of the element in the development of the central nervous 
system (Petersson Grawé et al., 2004b). Thus, it is of paramount importance 
to minimize cadmium exposure and uptake in newborns. Our hypothesis 
was that iron supplementation would be beneficial for the newborn to 
reduce the intestinal cadmium absorption. However, cadmium absorption in 
iron-deficient suckling piglets did not increase. In contrast, a higher 
cadmium uptake was detected in the iron-supplemented ones, suggesting 
that in newborns the cadmium absorption is more efficient following iron 
supplementation. The expressions and localizations of duodenal DMT1, 
FPN1 and MT in the piglets were not affected by iron status and could 
therefore not explain the increased cadmium uptake. In the immature Caco-
2 cell model we demonstrated that cadmium treatment of the cells 
upregulates MRP1, which correlated to an increased transport of the metal 
across the basolateral membrane. Furthermore, cadmium transport across 
immature Caco-2 cells was not decreased, but instead tended to be increased 
by iron, and is not dependent on DMT1 or FPN1 expressions and 
localizations. The expression of MT was induced by cadmium treatment and 
correlated to the increased transport of the metal across the immature 
intestinal cells. However, it is not clarified if the efflux of cadmium-MT 
complexes occurs from the intestinal cells.  
Supposedly, immature cells are more sensitive than mature cells to 
oxidative stress and therefore more prone to form cadmium-GSH 
complexes initiating upregulation of MRP1. As a result, neonates have a 
higher intestinal absorption of cadmium than adults. Our findings indicate 
that neonatal intestinal transport of cadmium is not restricted by iron; rather 
there is a tendency of an increased cadmium transport by treatment with 
cadmium plus iron. Our results also support the notion that intestinal iron 
homeostasis is not active at early age.    53
 
Figure 7. Proposed mechanism for cadmium transport in immature neonatal enterocytes. 
Panel A describes a schematic unexposed immature enterocyte and panel B describes a 
schematic cadmium exposed immature enterocyte. DMT1, divalent metal transporter 1; 
FPN1, ferroportin 1; MRP2, multidrug resistance associated protein 2; P-gp, plasma 
glycoprotein; MRP1, multidrug resistance associated protein 1; GSH, glutathione; X, 
endogenous or exogenous substrate; MT, metallothionein; N, nucleus; ER, endoplasmic 
reticulum; GA, Golgi apparatus.   54
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6  Concluding remarks and future 
perspectives 
In this thesis two transport pathways that cadmium interferes with during 
early life were identified. In the lactating mammary epithelium calcium 
homeostasis was affected by cadmium and in the neonatal intestine 
expression of the ABC-transporter MRP1 was affected.  
Cell models 
Mechanistic insights on cellular effects of cadmium in the mammary 
epithelium and neonatal intestine were obtained by combining in vivo and in 
vitro studies. The animal experiments were performed initially so that the 
cell models could be validated to distinguish relevant mechanisms.  
The HC11 cells have previously been used mainly to study the hormonal 
regulation of mammary cell differentiation. It is concluded that the HC11 
cell model is useful also to examine the impact of toxic compounds on the 
mammary epithelial cells.  
The immature Caco-2 cells constitutes a promising system for detailed 
studies concerning developmental changes in the intestinal transport of both 
cadmium and iron in newborns based on similar results in suckling piglets 
and in the cells, as well as the intracellular localization of iron transporters. It 
is concluded that the immature Caco-2 cell model may be used to study 
age-dependent intestinal absorption.  
Cadmium in the mammary epithelium 
The results indicate that cadmium disturbs the tightly regulated calcium 
homeostasis in the mammary epithelial cells leading to reduced expressions 
of SPCA and β-casein. The histological changes are involution-like in the 
mammary glands exposed to cadmium and resemble the effects observed in 
the tissue due to forced weaning. In addition to mammary gland, SPCA   56
protein expression is high in brain, testis and kidney (Xiang et al., 2005) and 
one could therefore suggest that the toxicity of cadmium may involve SPCA 
also in these tissues. Future research on SPCA expressions in these tissues 
following cadmium exposure is recommended. In conclusion, maternal 
cadmium exposure may disturb calcium regulation and decrease the levels of 
β-casein in milk with potential nutritional and developmental implications 
for the breast-fed newborn. 
Further studies are required to examine if the cadmium-induced effects 
in the mammary epithelium also involve other calcium transporters as the 
apical PMCA2 and basolateral TRPV6, or zinc transporters, particularly the 
apical efflux proteins ZnT1, 2 and 4. Zinc is necessary for the development 
of the newborn and several zinc transporters rigorously regulate the level of 
zinc in milk. Cadmium is known to affect zinc levels and zinc transporters 
by ionic mimicry. 
Generally, research on the mammary gland investigates breast cancer or 
lactational transfer of various compounds across the mammary epithelial 
cells. The focus in this thesis was effects in the mammary gland and its 
function following exposure to cadmium. The results demonstrate that 
cadmium disturbs the function of the mammary epithelial cells. Future 
studies should be performed to identify other chemicals having the potency 
to interfere with the function of mammary gland. 
Cadmium in the neonatal intestinal epithelium 
The results demonstrate that iron supplementation does not restrict 
cadmium absorption in neonates. The cadmium uptake was not higher in 
iron-deficient suckling piglets; rather, a higher cadmium uptake in the iron-
supplemented ones was detected. The expression and localization of DMT1, 
FPN1 and MT were not affected by iron status and could therefore not 
explain the increased cadmium uptake. The results suggest that the handling 
of both iron and cadmium in the intestinal epithelium is age-dependent and 
differs between newborns and adults. This should be taken into 
consideration in iron intervention programs for infants. Further, it appears 
that MRP1 plays a significant role in the absorption of cadmium and 
possibly also iron in neonatal intestine.  
Future studies applying specific MRP1 and P-gp inhibitors could give 
more detailed information about cadmium efflux from the immature 
enterocyte. Also the possible involvement of other ABC transporters as 
BCRP and CFTR in cadmium absorption remains to be investigated. The 
zinc transporters play important roles also in the intestine and there are 
studies suggesting that the regulation of zinc is immature in the neonatal   57
intestine (Jou et al., 2010). Therefore, studies investigating the impact of 
cadmium on zinc transporters in the immature intestine, particularly the 
basolateral efflux protein ZnT1 are encouraged. Furthermore, studies that 
examine indicators of oxidative stress e.g. GSH levels and SOD system 
activity, following cadmium exposure in immature intestinal cells are needed 
to increase the understanding of age-dependent cadmium absorption. 
In general, a more detailed understanding of mechanisms for cadmium-
induced disturbances in cellular calcium and generation of ROS requires 
further investigations. It is possible that calcium and ROS play major roles in 
the cellular toxicity of cadmium and may constitute the signal molecules 
initially affected by cadmium in all target organs. Therefore, research efforts 
are needed to understand if cadmium-induced disturbances in calcium 
homeostasis and ROS generation may be involved in the higher 
susceptibility to cadmium in neonates compared to adults.  
Conclusions 
Newborns and children are vulnerable groups for toxic effects of chemicals. 
Cadmium is ubiquitous in our environment and it is impossible to avoid 
exposure to the metal. In this thesis two new aspects concerning adverse 
health effects of cadmium during early life have been investigated and novel 
findings have been revealed:  
 
 
  Cadmium disturbs the milk synthesis in the mammary gland. The health 
consequences in neonates need to be studied as well as the potential of 
other toxic compounds to affect the mammary gland function.  
 
  The well-known association in adults between low iron status and high 
body burden of cadmium does not apply for neonates. Iron 
supplementation does not restrict, but rather increases cadmium 
absorption in neonates, which should be considered in risk assessment of 
cadmium.   58
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7  Populärvetenskaplig sammanfattning 
Kadmium är en toxisk metall som vi främst får i oss via livsmedel och 
tobaksrökning på grund av att metallen effektivt tas upp av växter som 
rotfrukter, grönsaker, spannmål och tobak. I jorden finns kadmium naturligt 
i varierande grad, men frisätts också genom mänskliga aktiviteter som 
exempelvis brytning i zinkgruvor där kadmium är en biprodukt. Kadmium 
används som metallegering, i nickel-kadmium batterier, som pigment och 
stabiliserare i plaster, och även i nya nanomaterial. Kemiskt liknar kadmium 
ett antal för kroppen nödvändiga (essentiella) metaller som behövs till en 
mängd olika funktioner, bland annat i röda blodkroppar, skelettet och 
många enzymer. På grund av likheten med de essentiella metallerna kan 
kadmium transporteras in och runt i kroppen av proteiner avsedda för 
exempelvis järn och kalcium.  
I över tvåhundra år har det varit känt att kadmium har toxiska effekter på 
människor. I vuxna är det främst njuren som skadas då kadmium ansamlas 
där och påverkar återupptaget av bland annat näringsämnen, mineraler och 
vitaminer. Negativa effekter av kadmium uppstår också i skelettet. Itai-itai-
sjukan som innebär att skelettet urkalkas och att spontana benfrakturer kan 
uppkomma upptäcktes första gången i Japan på 1950-talet efter att ris 
bevattnats med kadmiumhaltigt vatten. Femtio år senare står det klart att 
benskörhet kan orsakas även av ett relativt lågt intag av kadmium. Upptaget 
av kadmium från tarmen hos vuxna är mellan 3-5%, men varierar med bland 
annat ålder och näringsstatus, främst nivåer av järn men också kalcium.  
Hos nyfödda förefaller det centrala nervsystemet vara ett av de känsligaste 
organen för kadmiums skadliga effekter. Nyfödda har dessutom ett ökat 
upptag av kadmium från tarmen, vilket vi idag inte har någon förklaring till. 
Förutom att ansamlas i njuren har studier på gnagare visat att kadmium även 
ansamlas i mjölkproducerande bröstvävnad.   60
Carl von Linné döpte 1758 den grupp av djur som kan producera mjölk 
till sin avkomma för Mammalia (däggdjur, från ordet dägga, att ge di). Den 
stora fördelen att kunna ge di till sina ungar har varit avgörande för 
däggdjurens utveckling. I alla däggdjur finns det nära samband mellan den 
mjölkproducerande bröstvävnaden och avkommans tarmfunktion. Bröstet 
producerar mjölk som innehåller både näring och skydd, och avkommans 
tarm är beroende av mjölken för att kompensera för dess omogna funktioner 
samt för att mogna.  
I den här avhandlingen har kadmiums effekter under nyföddhetsperioden 
studerats, det vill säga motsvarande livets fyra första veckor hos människor. 
Målet har varit att studera kadmiums effekter på de bröstceller som 
producerar mjölk åt den nyfödde och att studera upptaget av kadmium från 
den nyföddes tarmar. Vi har använt oss av fyra olika modeller för våra 
studier: 1) mjölkproducerande möss; 2) odlade bröstceller; 3) diande 
griskultingar; 4) odlade omogna tarmceller som liknar den nyföddes tarmar. 
Resultaten i avhandlingen visar att kadmium har en förmåga att störa 
kalciumregleringen i den mjölkproducerande bröstvävnaden och att 
uttrycket av kalciumtransportören SPCA och mjölkproteinet -kasein 
minskar. Kadmium orsakade också förändringar av bröstvävnaden liknande 
de som uppkommer normalt i vävnaden vid avvänjning, då avkomman 
börjar äta fast föda och mjölkproduktionen upphör. Konsekvensen av att 
kadmium ansamlas i bröstvävnad kan därför bli att den nyfödde får i sig lägre 
halter av kalcium och protein, vilket kan leda till en generellt sämre 
utveckling och tillväxt. Kalciumtransportören SPCA finns förutom i 
bröstvävnad även i hög grad i hjärnan och njuren. Den eventuella effekten 
av kadmium på uttrycket av SPCA i dessa vävnader är ett viktigt område för 
framtida studier.  
Det har visat sig att vuxna människor som har låg järnstatus har förhöjda 
halter av kadmium i kroppen och mycket tyder på att det har med ett ökat 
uttryck i tarmen av de två järntransportörerna DMT1 och FPN1 att göra. I 
vår studie med diande griskultingar var resultatet mycket överraskande då 
upptaget av kadmium var högre hos grisar med hög järnstatus jämfört med 
låg järnstatus. Vidare visade det sig att järntransportörerna inte påverkades av 
järnstatus och de kunde därför inte vara inblandade i det ökade upptaget av 
kadmium. I cellmodellen med omogna tarmceller upptäcktes att den ökade 
kadmiumtransporten sammanföll med ett ökat uttryck av transportproteinet 
MRP1.   
Sammanfattningsvis visar resultaten i avhandlingen att kadmium kan störa 
funktionen i de mjölkproducerande cellerna. Mjölkproduktionen påverkas 
negativt och det i sin tur ger mindre näring och kalcium till den nyfödde.   61
Tidigare studier har visat att nyfödda har ett högre upptag av kadmium och 
att även att kadmium kan lagras in i den omogna njuren. Då kadmium har 
en mycket lång halveringstid i njuren (10-30 år) är det av stor vikt att 
minimera kadmiumexponeringen särskilt vid unga år. Våra resultat visar att 
åldersberoende skillnader gör att järntillskott inte begränsar kadmium-
upptaget från tarmen hos den nyfödde. Resultaten ger nya insikter om 
kadmiums effekter under nyföddhetsperioden och visar på viktiga skillnader 
mellan hur kadmium hanteras hos nyfödda jämfört med vuxna.  
Slutsatser 
Nyfödda och barn är känsliga grupper som vi behöver mer kunskap om när 
det gäller påverkan av miljöföroreningar. Kadmium finns överallt i vår natur 
och vi kan omöjligt undgå att få i oss metallen. I den här avhandlingen har 
kadmiums effekter under nyföddhetsperioden studerats ur två nya 
perspektiv. Resultaten visar att: 
 
  Kadmium kan störa mjölkproduktionen i bröstvävnaden. Betydelsen av 
fyndet för den nyfödde kvarstår att undersöka. Det är också viktigt att 
studera om det finns andra miljöföroreningar som har förmågan att störa 
mjölkproduktionen i bröstet. 
 
  Det välkända sambandet hos vuxna mellan låg järnstatus och högt upptag 
av kadmium gäller inte för nyfödda. Järntillskott begränsar inte, utan 
tycks istället öka kadmiumupptaget hos nyfödda, vilket bör beaktas vid 
riskbedömning av kadmium.    62
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